CY1107911T1 - Διαταξη αφαιρεσεως - Google Patents

Διαταξη αφαιρεσεως

Info

Publication number
CY1107911T1
CY1107911T1 CY20081100330T CY081100330T CY1107911T1 CY 1107911 T1 CY1107911 T1 CY 1107911T1 CY 20081100330 T CY20081100330 T CY 20081100330T CY 081100330 T CY081100330 T CY 081100330T CY 1107911 T1 CY1107911 T1 CY 1107911T1
Authority
CY
Cyprus
Prior art keywords
removal provision
provision
removal
alzheimer
patients
Prior art date
Application number
CY20081100330T
Other languages
Greek (el)
English (en)
Inventor
Frank Mattner
Walter Schmidt
Original Assignee
Affiris Forschungs - Und Entwicklungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107911(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affiris Forschungs - Und Entwicklungs Gmbh filed Critical Affiris Forschungs - Und Entwicklungs Gmbh
Publication of CY1107911T1 publication Critical patent/CY1107911T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
CY20081100330T 2003-09-12 2008-03-21 Διαταξη αφαιρεσεως CY1107911T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0144403A AT413336B (de) 2003-09-12 2003-09-12 Apherese-vorrichtung
EP04761033A EP1663347B1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung

Publications (1)

Publication Number Publication Date
CY1107911T1 true CY1107911T1 (el) 2013-09-04

Family

ID=34280361

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100330T CY1107911T1 (el) 2003-09-12 2008-03-21 Διαταξη αφαιρεσεως

Country Status (15)

Country Link
US (2) US7935252B2 (cg-RX-API-DMAC7.html)
EP (1) EP1663347B1 (cg-RX-API-DMAC7.html)
JP (1) JP4509113B2 (cg-RX-API-DMAC7.html)
CN (1) CN100556472C (cg-RX-API-DMAC7.html)
AT (2) AT413336B (cg-RX-API-DMAC7.html)
AU (1) AU2004271651B2 (cg-RX-API-DMAC7.html)
CA (1) CA2538305C (cg-RX-API-DMAC7.html)
CY (1) CY1107911T1 (cg-RX-API-DMAC7.html)
DE (1) DE502004005851D1 (cg-RX-API-DMAC7.html)
DK (1) DK1663347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2298789T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080090T3 (cg-RX-API-DMAC7.html)
PL (1) PL1663347T3 (cg-RX-API-DMAC7.html)
PT (1) PT1663347E (cg-RX-API-DMAC7.html)
WO (1) WO2005025651A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) * 2005-03-15 2006-10-15 Mattner Frank Dr Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) * 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
JP2011508622A (ja) * 2007-12-21 2011-03-17 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー 化学的に活性化された固相支持体材料の滅菌のための方法
EP2320987A1 (en) * 2008-07-29 2011-05-18 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
CA2748561C (en) * 2008-12-22 2016-11-01 Kaneka Corporation A.beta. remover, a.beta. removing apparatus and a.beta. removal system
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
PT2579042E (pt) 2011-10-04 2014-09-09 Affiris Ag Método para detecção de anticorpos específicos para a numa amostra biológica.
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
AU2015286606A1 (en) 2014-07-10 2017-01-12 Affiris Ag Substances and methods for the use in prevention and/or treatment in huntington's disease
CN107074925B (zh) 2014-07-10 2021-08-24 阿费里斯股份公司 用于预防和/或治疗亨廷顿氏病的物质和方法
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
EP0236509B1 (en) 1985-09-19 1993-02-10 Toray Industries, Inc. B2-microglobulin-removing column
JPH01171638A (ja) * 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
DE3880647T2 (de) * 1987-11-20 1993-11-18 Kanegafuchi Chemical Ind Sorbentmittel für Serum-Amyloid-Proteine.
US5216127A (en) * 1987-11-20 1993-06-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for serum amyloid protein
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja) 1992-09-21 1994-04-15 Matsushita Electric Ind Co Ltd ロータリートランス
AU691297B2 (en) * 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
DE1257584T1 (de) 2000-02-24 2003-05-28 Lilly Co Eli Humanisierte antikörper, die amyloid beta peptid demarkieren
TWI238251B (en) * 2000-07-13 2005-08-21 Anawrhta Biotech Co Ltd In-vitro adsorbing device using immunity
WO2003051374A2 (en) * 2001-12-17 2003-06-26 New York State Office Of Mental Health SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
AU2003303198A1 (en) * 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh Cholinestertransport-protein-mimotop als atherosklerose-medikament

Also Published As

Publication number Publication date
AT413336B (de) 2006-02-15
ES2298789T3 (es) 2008-05-16
ATA14442003A (de) 2005-07-15
AU2004271651A1 (en) 2005-03-24
JP2007504863A (ja) 2007-03-08
CA2538305C (en) 2011-05-24
HK1096320A1 (zh) 2007-06-01
JP4509113B2 (ja) 2010-07-21
DK1663347T3 (da) 2008-05-19
PL1663347T3 (pl) 2008-06-30
CN100556472C (zh) 2009-11-04
ATE382383T1 (de) 2008-01-15
DE502004005851D1 (de) 2008-02-14
US20070026029A1 (en) 2007-02-01
HRP20080090T3 (hr) 2008-03-31
EP1663347A1 (de) 2006-06-07
EP1663347B1 (de) 2008-01-02
AU2004271651B2 (en) 2009-08-06
CN1867365A (zh) 2006-11-22
US20110166327A1 (en) 2011-07-07
CA2538305A1 (en) 2005-03-24
WO2005025651A1 (de) 2005-03-24
US7935252B2 (en) 2011-05-03
PT1663347E (pt) 2008-03-28

Similar Documents

Publication Publication Date Title
CY1107911T1 (el) Διαταξη αφαιρεσεως
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
DE60328797D1 (de) Blutbehandlungsgerät
FR2843693B1 (fr) Appareil medical, en particulier ecarteur de vertebres
MXPA03000263A (es) Correlacion del objetivo de fuentes multiples.
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
DE60323136D1 (de) Vakuumunterstützte chirurgische klammervorrichtung
CY1115871T1 (el) Μεθοδοι για την αντιμετωπιση ουρικης αρθριτιδας
ATE442871T1 (de) Antimikrobielle medizinprodukte
DE602004031162D1 (de) Chirurgische Klemmanordnung
ATE498134T1 (de) Nachweis von staphylococcus
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
DE602004012562D1 (de) Strahlaufbereitungssystem
BRPI0407319B1 (pt) aparelho de bandeja de contato de vapor-lÍquido.
SE0302304D0 (sv) Novel compounds
UY28344A1 (es) Nuevos compuestos
ATE515280T1 (de) Vorrichtung zur intermittierenden okklusion des koronarsinus
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DE602005019341D1 (de) System zur Behandlung von Sterilisationskassetten mit visuellem Dual-Kode Leser
DE50309647D1 (de) Ng fibrotischer erkrankungen
DK1713438T3 (da) Medicinsk sæbe
ITBO20020678A0 (it) Manipolo dentale per la rimozione del tartaro.
EP1654537A4 (en) TSSK4: A HUMAN TESTISS-SPECIFIC SERIN / THREONIN KINASE